StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Cell Therapeutics, Inc. (CTIC) Misses Q4 EPS by 4c
April 27, 2011 7:23 AM
Cell Therapeutics, Inc. (NASDAQ:
CTIC
) reported Q4 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02).
Categories
Earnings